Effect of and biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 80, Issue 2, 2007, Pages 433-439

  Zimmermann, Anja K ^a   Weber, Norbert ^a,b   Aebert, Hermann ^a   Ziemer, Gerhard ^a   Wendel, Hans P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

Author keywords

Extracorporeal circulation; Fibrinogen adsorption; Hemocompatibility; Oxygenator; Platelet receptor GPIIb IIIa; Surface coating

Indexed keywords

ADHESION; ADSORPTION; BLOOD; INORGANIC COATINGS; OXYGENATORS; SURGERY;

EXTRACORPOREAL CIRCULATION; FIBRINOGEN ADSORPTION; HEMOCOMPATIBILITY; OXYGENATOR; PLATELET RECEPTOR GPIIB-IIIA;

BIOMATERIALS;

BETA THROMBOGLOBULIN; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C5A; ELASTASE; FIBRINOGEN; FIBRINOGEN RECEPTOR; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOCYTE RECEPTOR;

ADSORPTION; ARTICLE; BIOCOMPATIBILITY; BLOOD; BLOOD COMPATIBILITY; CARDIOPULMONARY BYPASS; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; DEVICE; EXTRACORPOREAL CIRCULATION; HUMAN; HUMAN CELL; LEUKOCYTE ADHERENCE; MATERIAL COATING; OXYGENATOR; POSTOPERATIVE COMPLICATION; PROTEIN BLOOD LEVEL; RECEPTOR BINDING; SIMULATION; THROMBOCYTE ADHESION;

ADSORPTION; BLOOD COAGULATION; CELL ADHESION; COATED MATERIALS, BIOCOMPATIBLE; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS; EXTRACORPOREAL CIRCULATION; FIBRINOGEN; HUMANS; LEUKOCYTES; MATERIALS TESTING; OXYGENATORS, MEMBRANE; PLATELET ADHESIVENESS; PLATELET MEMBRANE GLYCOPROTEINS; POSTOPERATIVE COMPLICATIONS;

EID: 33847003023     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.30614     Document Type: Article

References (38)

1. Gibbon JR. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954;37:171-180.
2. Daly RC, Dearani JA, McGregor CG, Mullany CJ, Orszulak TA, Puga FJ, Schaff HV, Sundt TM III, Zehr KJ. Fifty years of open heart surgery at the Mayo Clinic. Mayo Clin Proc 2005;80:636-640.
3. Wendel HP, Ziemer G. Coating-techniques to improve the hemocompatibility of artificial surfaces used for extracorporeal circulation. Eur J Cardiothorac Surg 1999;16:342-350.
4. Horbett TA. Principles underlying the role of adsorbed plasma proteins in blood interactions with foreign materials. Cardiovasc Pathol 1993;2:137-148.
5. Ratner BD. The blood compatibility catastrophe. J Biomed Mater Res 1993;27:283-287.
6. Nieman G, Searles B, Carney D, McCann U, Schiller H, Lutz C, Finck C, Gatto LA, Hodell M, Picone A. Systemic inflammation induced by cardiopulmonary bypass: A review of pathogenesis and treatment. J Extra Corpor Technol 1999;31:202-210.
7. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-857.
8. Harig F, Feyrer R, Mahmoud FO, Blum U, von der Emde J. Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin. Thorac Cardiovasc Surg 1999;47:111-118.
9. Belboul A, al-Khaja N. Does heparin coating improve biocompatibility? A study on complement, blood cells and postoperative morbidity during cardiac surgery. Perfusion 1997;12:385-391.
10. Kerbaul F, Guidon C, Lejeune PJ, Mollo M, Mesana T, Gouin F. Hyperprocalcitonemia is related to noninfectious postoperative severe systemic inflammatory response syndrome associated with cardiovascular dysfunction after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth 2002;16:47-53.
11. Keuren JF, Wielders SJ, Willems GM, Morra M, Lindhout T. Fibrinogen adsorption, platelet adhesion and thrombin generation at heparinized surfaces exposed to flowing blood. Thromb Haemost 2002;87:742-747.
12. Lundblad R, Moen O, Fosse E. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997;63:1361-1367.
13. Muehrcke DD, McCarthy PM, Kottke-Marchant K, Harasaki H, Pierre-Yared J, Borsh JA, Ogella DA, Cosgrove DM. Biocompatibility of heparin-coated extracorporeal bypass circuits: A randomized, masked clinical trial. J Thorac Cardiovasc Surg 1996;112:472-483.
14. Korn RL, Fisher CA, Livingston ER, Stenach N, Fishman SJ, Jeevanadam V, Addonizio VP. The effects of Carmeda Bioactive Surface on human blood components during simulated extracorporeal circulation. J Thorac Cardiovasc Surg 1996;111:1073-1084.
15. Fukutomi M, Kobayashi S, Niwaya K, Hamada Y, Kitamura S. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment. Artif Organs 1996;20:767-776.
16. Wendel HP, Heller W, Gallimore MJ, Hoffmeister HE. Heparin-coated oxygenators significantly reduce contact system activation in an ex-vivo cardiopulmonary bypass model. Blood Coagul Fibrinolysis 1994;5:673-678.
17. Salzman E, Merril E, Kent K. Interaction of blood with artificial surfaces. In: Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD, editors. Haemostasis and Thrombosis. Edinburgh: Churchill Livingstone; 1994. pp 1469-1485.
18. Tsai WB, Grunkemeier JM, McFarland CD, Horbett TA. Platelet adhesion to polystyrene-based surfaces preadsorbed with plasmas selectively depleted in fibrinogen, fibronectin, vitronectin, or von Willebrand's factor. J Biomed Mater Res 2002;60:348-359.
19. Wendel HP, Philipp PA, Weber N, Birnbaum DE, Ziemer G. Oxygenator thrombosis: Worst case after development of an abnormal pressure gradient-incidence and pathway. Perfusion 2001;16:271-278.
20. Weber N, Wendel HP, Ziemer G. Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption. Biomaterials 2002;23:429-439.
21. Mulzer SR, Brash JL. Analysis of proteins adsorbed to glass from human plasma using immunoblotting methods. J Biomater Sci Polym Ed 1990;1:173-182.
22. Calvete JJ, Henschen A, Gonzalez-Rodriguez J. Complete localization of the intrachain disulphide bonds and the N-glycosylation points in the α-subunit of human platelet glycoprotein IIb. Biochem J 1989;261:561-568.
23. Mulholland JW, Massey W, Shelton JC. Investigation and quantification of the blood trauma caused by the combined dynamic forces experienced during cardiopulmonary bypass. Perfusion 2000;15:485-494.
24. Eisses MJ, Seidel K, Aldea GS, Chandler WL. Reducing hemostatic activation during cardiopulmonary bypass: A combined approach. Anesth Analg 2004;98:1208-1216.
25. Weiland AP, Walker WE. Physiologic principles and clinical sequelae of cardiopulmonary bypass. Heart Lung 1986;15:34-39.
26. Whitten CW, Hill GE, Ivy R, Greilich PE, Lipton JM. Does the duration of cardiopulmonary bypass or aortic cross-clamp, in the absence of blood and/or blood product administration, influence the IL-6 response to cardiac surgery? Anesth Analg 1998;86:28-33.
27. Nagai H, Handa M, Kawai Y, Watanabe K, Ikeda Y. Evidence that plasma fibrinogen and platelet membrane GPIIb-IIIa are involved in the adhesion of platelets to an artificial surface exposed to plasma. Thromb Res 1993;71:467-477.
28. Musial J, Niewiarowski S, Hershock D, Morinelli TA, Colman RW, Edmunds LH Jr. Loss of fibrinogen receptors from the platelet surface during simulated extracorporeal circulation. J Lab Clin Med 1985;105:514-522.
29. Edmunds LH Jr, Ellison N, Colman RW, Niewiarowski S, Rao AK, Addonizio VP Jr, Stephenson LW, Edie RN. Platelet function during cardiac operation: Comparison of membrane and bubble oxygenators. J Thorac Cardiovasc Surg 1982;83:805-812.
30. Harker LA, Malpass TW, Branson HE, Hessel EA II, Slichter SJ. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective α-granule release. Blood 1980;56:824-834.
31. Wenger RK, Lukasiewicz H, Mikuta BS, Niewiarowski S, Edmunds LH Jr. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989;97:235-239.
32. Balasubramanian V, Grusin NK, Bucher RW, Turitto VT, Slack SM. Residence-time dependent changes in fibrinogen adsorbed to polymeric biomaterials. J Biomed Mater Res 1999;44:253-260.
33. Li J, Sly MK, Chao R, Constantinescu A, Kulkarni PV, Wians FH Jr, Jessen ME, Eberhart RC. Transient adhesion of platelets in pump-oxygenator systems: Influence of SMA and nitric oxide treatments. J Biomater Sc Polym Ed 1999;10:235-246.
34. Hsu LC. Heparin-coated cardiopulmonary bypass circuits: Current status. Perfusion 2001;16:417-428.
35. Sanchez J, Elgue G, Riesenfeld J, Olsson P. Control of contact activation on end-point immobilized heparin: The role of antithrombin and the specific antithrombin-binding sequence. J Biomed Mater Res 1995;29:655-661.
36. Hind CR, Griffin JF, Pack S, Latchman YE, Drake HF, Jones HM, Brostoff J, Dormandy TL, Treasures T. Effect of cardiopulmonary bypass on circulating concentrations of leucocyte elastase and free radical activity. Cardiovasc Res 1988;22:37-41.
37. de Vroege R, van Oeveren W, van Klarenbosch J, Stooker W, Huybregts MA, Hack CE, van Barneveld L, Eijsman L, Wildevuur CR. The impact of heparin-coated cardiopulmonary bypass circuits on pulmonary function and the release of inflammatory mediators. Anesth Analg 2004;98:1586-1594.
38. Hsu LC. Biocompatibility in cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997;11:376-382.